SANTA CLARA, California, March 7 /PRNewswire/ --

Finesse Solutions, LLC, a manufacturer of measurement and control solutions for life sciences process applications, and Nova Biomedical, Waltham, MA, a world leader in biotechnology process monitoring announced the first TruBio(TM) OS plug-in for OPC connectivity between TruBio(TM) OS and Nova BioProfile 400, 100 Plus, Basic 4 and Basic 2 analyzers. Both companies confirmed that a TruBio(TM) OS plug-in for OPC connectivity to the Nova Flex is currently in development.

SANTA CLARA, California, March 6 /PRNewswire/ --

Finesse Solutions, LLC, a manufacturer of measurement and control solutions for life sciences process applications, announced the opening of its new sales and service center in Northborough, MA, in order to support its east coast customer base. Additionally, Finesse Solutions is converting its Irvine, CA facility to a service center for its west coast customer base. The company also plans on opening a European sales and service center in the summer of 2008, and additional sales and service centers in the U.S. by the end of 2008.

WASHINGTON, March 6 /PRNewswire/ --

Global power generated by nuclear reactors fell about 3.6% in calendar 2007 from the 2.8 billion megawatt-hours (MWh) recorded in 2006, according to data released by Nucleonics Week, a publication of Platts, a leading global provider of energy and commodities information.

In the otherwise lackluster 2007, US reactors set a record for nuclear power generation, with output surging to 843 million gross MWh and utilizing an average 91% of reactor capacity.

"The 2007 nuclear plant performance means about 20% of US electricity was once again generated without the carbon emissions that would otherwise contribute to global warming," said Margaret Ryan, Platts global nuclear editorial director.

NEW YORK and DUBLIN, Ireland, March 6 /PRNewswire/ --

- Transaction Joins the World's Largest Provider of Visual Localisation Software with Global Leader in Software Localisation Services and Technology

MOUNTAIN VIEW, California, March 6 /PRNewswire/ --

Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients, today announced that the results of its Multi MERCI trial will be published in the April 2008 edition of the medical journal, Stroke. The Multi MERCI trial was the second trial studying safety and efficacy of the Merci Retrieval System(TM), a "corkscrew-type" device that is delivered into the brain and is designed to restore blood flow by engaging, capturing and removing blood clots that cause ischemic stroke. The full, peer reviewed trial results are available now to online subscribers. Stroke is published by the American Heart Association.

LONDON, March 6 /PRNewswire/ -- Responding to the announcement by Public Health Minister Dawn Primarolo today that prescription charge increases will stay below the rate of inflation, Paul Bennett, Chairman of the Royal Pharmaceutical Society of Great Britain's English Pharmacy Board, said:

"We urgently need a review of the current system of prescription charges and exemptions in England - they are presently both illogical and unfair. There are clear disadvantages under existing arrangements, particularly for non-exempt patients, such as asthma and arthritis sufferers, who require long-term medication for multiple chronic conditions.